Wird geladen...
Selecting treatment options in refractory metastatic colorectal cancer
Survival of patients with metastatic colorectal cancer (mCRC) has significantly improved in the last decade. Survival gains are not driven by advances in first-line therapy but by incremental additional effects of subsequent treatment lines. To maximize outcomes, patients should receive all active a...
Gespeichert in:
| Veröffentlicht in: | Onco Targets Ther |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Dove Medical Press
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6441549/ https://ncbi.nlm.nih.gov/pubmed/30988631 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S194605 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|